Marvell Technology, Inc. (MRVL)
Marvell Technology surges after Nvidia's Huang calls it 'next trillion-dollar company'
Marvell Technology's shares surged more than 24% in premarket trading on Tuesday after Nvidia CEO Jensen Huang called the chipmaker the next "trillion-dollar company."
Marvell: I Exited For +112%, But AI Euphoria May Run Further (Rating Downgrade)
Marvell Technology, Inc. has surged +125% since my last Strong Buy, but I now rate it Hold due to valuation concerns. MRVL's business thesis has strengthened, with record Q1 operating cash flow and robust AI-driven data center revenue growth. At $205, MRVL stock trades at ~70x trailing and 50x forward earnings, with limited margin of safety and consensus showing only 8% further upside.
Nvidia Validated Marvell's Biggest Growth Driver
Nvidia Validated Marvell's Biggest Growth Driver
Interpreting Marvell (MRVL) International Revenue Trends
Explore how Marvell's (MRVL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Marvell Technology: AI Growth Catalyst Is Kicking Off
Marvell Technology (MRVL) is capitalizing on soaring custom AI chip demand and robust Data Center buildouts, driving record financial performance. MRVL reported record Q1 revenues of $2.4B, up 28% year-over-year, and delivered a beat on both top and bottom lines. An expanding AI-driven custom silicon business positions MRVL as an essential enabler of hyperscale AI infrastructure.
MRVL Experiences Slow Expansion in Gross Margin: What's Ahead?
Marvell Technology's AI chip demand is driving revenue growth, but gross margin remains under pressure as custom silicon costs rise and competition intensifies.
Marvell's Pullback May Be the Setup Bulls Were Waiting For
Marvell Technology's NASDAQ: MRVL market signaled a top in late May, gapping up after the strong fiscal Q1 2027 results to fall from the high and create an ominous candle.
Marvell Technology Q1 Earnings Match Estimates, Revenues Rise Y/Y
MRVL's AI-fueled data center growth drives record Q1 revenues as MRVL raises fiscal 2027 and 2028 outlooks.
Imugene doses first patient in BTKi combination cohort for azer-cel study
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has dosed the first patient in the Bruton Tyrosine Kinase inhibitor (BTKi) combination cohort of its Phase 1b...
Solis Minerals to outline Brazil lithium drilling plans in investor webinar
Solis Minerals Ltd (TSX-V:SLMN, ASX:SLM, OTCQB:SLMFF, FRA:08WA) will brief investors on Friday about preparations for its upcoming Brazil lithium drilling...
International Graphite secures building permit for Collie Micronising Facility
International Graphite Ltd (ASX:IG6, FRA:H99, OTC:IGRPF) has received a Building Permit from the Shire of Collie, clearing the way for earthworks and civil...
MRVL Q1 Earnings Call Lifts AI Growth Targets
Marvell boosts FY27 and FY28 revenue targets as AI networking demand surges, spotlighting interconnect, switching and custom silicon momentum.
